Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2025-12-25 @ 3:30 AM
NCT ID:
NCT00662805
Eligibility Criteria:
Inclusion Criteria:
* Subject should fulfill criteria for the subscription of SERETIDE as these are mentioned in SPC.
Exclusion Criteria:
* Hypersensitivity to Salmeterol + Fluticasone or any of its excipients
* Pregnancy, lactation or scheduled pregnancy during the observational period of the study
* Serious illness/disease, not adequately controlled, or with a potential to interfere with the patients' participation in the present study, according to the investigator/physician's judgment.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00662805
Study Brief:
Protocol Section:
NCT00662805